Free Trial

Mesabi Trust (MSB) Financials

Mesabi Trust logo
$17.76 -0.07 (-0.36%)
Closing price 10/13/2026 03:59 PM Eastern
Extended Trading
$17.75 -0.02 (-0.09%)
As of 10/13/2026 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Mesabi Trust

Annual Income Statements for Mesabi Trust

This table shows Mesabi Trust's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/31/2016 1/31/2017 1/31/2018 1/31/2019 1/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025 1/31/2026
Net Income / (Loss) Attributable to Common Shareholders
8.56 9.76 33 46 30 23 69 5.31 19 93 14
Consolidated Net Income / (Loss)
8.56 9.76 33 46 30 23 69 5.31 19 93 14
Net Income / (Loss) Continuing Operations
8.56 9.76 33 46 30 23 69 5.31 19 93 14
Total Pre-Tax Income
8.56 9.76 33 46 30 23 69 5.31 19 93 14
Total Operating Income
8.56 9.76 33 46 30 23 69 5.31 19 93 14
Total Gross Profit
9.47 11 34 47 32 26 71 7.35 23 98 17
Total Revenue
9.72 11 34 47 32 26 71 7.74 23 99 18
Operating Revenue
9.72 11 34 47 32 26 71 7.74 23 99 18
Total Cost of Revenue
0.25 0.25 0.27 0.33 0.33 0.28 0.35 0.39 0.32 0.32 0.52
Operating Cost of Revenue
0.19 0.19 0.21 0.26 0.27 0.22 0.29 0.33 0.26 0.26 0.46
Other Cost of Revenue
0.06 0.06 0.06 0.06 0.06 0.06 0.06 0.06 0.06 0.06 0.06
Total Operating Expenses
0.91 0.87 0.80 1.41 1.60 2.27 2.34 2.04 3.56 5.00 3.14
Selling, General & Admin Expense
0.07 0.12 0.05 0.41 0.25 0.34 0.05 0.05 0.33 0.50 0.18
Other Operating Expenses / (Income)
0.35 0.36 0.38 0.37 0.42 0.47 0.56 0.61 0.66 0.65 0.66
Other Special Charges / (Income)
0.49 0.40 0.37 0.64 0.93 1.46 1.73 1.37 2.57 3.85 2.29
Total Other Income / (Expense), net
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Basic Earnings per Share
$0.65 $0.74 $2.55 $3.47 $2.29 $1.78 $5.24 $0.41 $1.45 $7.11 $1.06
Weighted Average Basic Shares Outstanding
13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M
Weighted Average Diluted Shares Outstanding
13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M
Weighted Average Basic & Diluted Shares Outstanding
13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M

Quarterly Income Statements for Mesabi Trust

This table shows Mesabi Trust's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027 Q2 2027
Period end date 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 10/31/2025 1/31/2026 4/30/2026 7/31/2026
Net Income / (Loss) Attributable to Common Shareholders
4.69 3.48 5.40 78 6.07 3.63 4.74 2.77 2.73 1.09 -0.10
Consolidated Net Income / (Loss)
4.69 3.48 5.40 78 6.07 3.63 4.74 2.77 2.73 1.09 -0.10
Net Income / (Loss) Continuing Operations
4.69 3.48 5.40 79 5.60 3.63 4.74 2.77 2.73 1.09 -0.10
Total Pre-Tax Income
4.69 3.48 5.40 79 5.60 3.63 4.74 2.77 2.73 1.09 -0.10
Total Operating Income
4.69 3.48 5.40 78 6.07 3.63 4.74 2.77 2.73 1.09 -0.10
Total Gross Profit
8.25 3.48 5.40 78 11 3.63 4.74 2.77 5.86 1.09 -0.10
Total Revenue
6.23 6.25 6.49 79 6.85 4.73 5.61 3.59 3.59 2.25 2.48
Operating Revenue
6.23 6.25 6.49 79 6.85 4.73 5.61 3.59 3.59 2.25 2.48
Total Cost of Revenue
-2.02 2.77 1.09 0.68 -4.22 1.10 0.86 0.82 -2.27 1.16 2.58
Operating Cost of Revenue
-2.08 2.77 1.09 0.68 -4.28 1.10 0.86 0.82 -2.33 1.16 2.58
Total Operating Expenses
3.56 0.00 0.00 0.00 5.00 0.00 0.00 0.00 3.14 0.00 0.00
Total Other Income / (Expense), net
- 0.00 0.00 0.47 -0.47 0.00 0.00 0.00 - 0.00 0.00
Basic Earnings per Share
$0.36 $0.27 $0.41 $5.97 $0.46 $0.28 $0.36 $0.21 $0.21 $0.08 ($0.01)
Weighted Average Basic Shares Outstanding
13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M
Weighted Average Diluted Shares Outstanding
13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M
Weighted Average Basic & Diluted Shares Outstanding
13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M

Annual Cash Flow Statements for Mesabi Trust

This table details how cash moves in and out of Mesabi Trust's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/31/2016 1/31/2017 1/31/2018 1/31/2019 1/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025 1/31/2026
Net Change in Cash & Equivalents
-6.13 11 -13 0.57 9.30 2.32 35 -34 10 76 -77
Net Cash From Operating Activities
8.22 13 30 45 35 21 63 14 15 94 14
Net Cash From Continuing Operating Activities
8.22 13 30 45 35 21 63 14 15 94 14
Net Income / (Loss) Continuing Operations
8.56 9.76 33 46 30 23 69 5.31 19 93 14
Consolidated Net Income / (Loss)
8.56 9.76 33 46 30 23 69 5.31 19 93 14
Non-Cash Adjustments To Reconcile Net Income
- -0.15 0.07 0.04 0.06 -0.18 -1.25 1.43 -0.45 0.21 -0.02
Changes in Operating Assets and Liabilities, net
-0.34 2.97 -3.99 -0.11 4.48 -2.42 -4.67 7.12 -3.93 0.45 0.56
Net Cash From Investing Activities
-5.43 5.74 -23 -8.32 19 3.43 9.91 0.00 0.00 0.00 0.00
Net Cash From Continuing Investing Activities
-5.43 5.74 -23 -8.32 19 3.43 9.91 0.00 0.00 0.00 0.00
Net Cash From Financing Activities
-8.92 -7.22 -20 -37 -44 -22 -38 -48 -4.59 -18 -91
Net Cash From Continuing Financing Activities
-8.92 -7.22 -20 -37 -44 -22 -38 -48 -4.59 -18 -91
Payment of Dividends
-8.92 -7.22 -20 -37 -44 -22 -38 -48 -4.59 -18 -91

Quarterly Cash Flow Statements for Mesabi Trust

This table details how cash moves in and out of Mesabi Trust's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027 Q2 2027
Period end date 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 10/31/2025 1/31/2026 4/30/2026 7/31/2026
Net Change in Cash & Equivalents
1.07 -2.35 0.00 74 4.29 -76 -2.97 1.94 -0.03 -2.88 -2.90
Net Cash From Operating Activities
5.66 2.50 3.81 78 9.41 2.08 4.38 3.52 4.43 0.53 0.25
Net Cash From Continuing Operating Activities
5.66 2.50 3.81 78 9.41 2.08 4.38 3.52 4.43 0.53 0.25
Net Income / (Loss) Continuing Operations
4.69 3.48 5.40 78 6.07 3.63 4.74 2.77 2.73 1.09 -0.10
Consolidated Net Income / (Loss)
4.69 3.48 5.40 78 6.07 3.63 4.74 2.77 2.73 1.09 -0.10
Non-Cash Adjustments To Reconcile Net Income
0.55 -1.11 -0.18 1.07 0.43 -0.94 -0.59 0.71 0.79 -0.60 -0.18
Changes in Operating Assets and Liabilities, net
0.42 0.13 -1.41 -1.18 2.92 -0.61 0.22 0.04 0.91 0.05 0.53
Net Cash From Financing Activities
-4.59 -4.85 -3.80 -3.94 -5.12 -78 -7.35 -1.57 -4.46 -3.41 -3.15
Net Cash From Continuing Financing Activities
-4.59 -4.85 -3.80 -3.94 -5.12 -78 -7.35 -1.57 -4.46 -3.41 -3.15
Payment of Dividends
-4.59 -4.85 -3.80 -3.94 -5.12 -78 -7.35 -1.57 -4.46 -3.41 -3.15

Annual Balance Sheets for Mesabi Trust

This table presents Mesabi Trust's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/31/2016 1/31/2017 1/31/2018 1/31/2019 1/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025 1/31/2026
Total Assets
9.82 14 26 35 24 23 54 14 27 102 24
Total Current Assets
9.36 14 26 35 24 23 54 14 27 102 24
Cash & Equivalents
2.59 14 0.31 0.88 10 13 48 14 24 100 23
Accounts Receivable
- - 1.96 2.34 0.07 0.25 4.63 0.02 1.96 1.16 0.78
Prepaid Expenses
0.05 0.05 0.05 0.05 0.07 0.09 0.12 0.13 0.30 0.12 0.15
Plant, Property, & Equipment, net
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Plant, Property & Equipment, gross
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Noncurrent Assets
0.46 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Liabilities & Shareholders' Equity
9.82 14 26 35 24 23 54 14 27 102 24
Total Liabilities
0.83 4.04 16 19 12 6.45 23 2.68 5.72 78 3.95
Total Current Liabilities
0.83 1.94 16 19 9.30 6.45 23 0.38 5.72 78 3.95
Accrued Expenses
0.17 0.11 0.13 0.41 0.12 0.42 0.16 0.38 0.86 0.34 0.54
Dividends Payable
0.66 1.84 15 18 9.18 6.04 23 0.00 4.85 78 3.41
Total Noncurrent Liabilities
0.00 2.10 0.00 0.00 2.51 0.00 0.00 2.30 0.00 0.00 0.00
Other Noncurrent Operating Liabilities
0.00 0.00 0.00 0.00 2.51 0.00 0.00 2.30 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
8.99 10 11 17 12 16 31 11 21 23 20
Total Preferred & Common Equity
8.99 10 11 17 12 16 31 11 21 23 20
Total Common Equity
8.99 10 11 17 12 16 31 11 21 23 20
Other Equity Adjustments
8.99 10 11 17 12 16 31 11 21 23 20

Quarterly Balance Sheets for Mesabi Trust

This table presents Mesabi Trust's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026 Q1 2027 Q2 2027
Period end date 4/30/2023 7/31/2023 10/31/2023 4/30/2024 7/31/2024 10/31/2024 4/30/2025 7/31/2025 10/31/2025 4/30/2026 7/31/2026
Total Assets
15 22 26 25 26 101 27 25 26 22 20
Total Current Assets
15 22 26 25 26 101 27 25 26 22 20
Cash & Equivalents
13 18 23 22 22 96 24 21 23 20 17
Accounts Receivable
1.39 1.81 1.89 1.83 2.58 3.88 1.92 1.44 1.52 0.63 0.97
Prepaid Expenses
0.11 0.30 0.21 0.11 0.29 0.20 0.11 0.32 0.23 0.14 0.44
Plant, Property, & Equipment, net
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Plant, Property & Equipment, gross
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Noncurrent Assets
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Liabilities & Shareholders' Equity
15 22 26 25 26 101 27 25 26 22 20
Total Liabilities
2.14 0.26 4.87 4.48 4.13 5.34 7.82 2.00 4.91 3.58 2.25
Total Current Liabilities
0.22 0.26 4.87 4.48 4.13 5.34 7.82 2.00 4.91 3.58 2.25
Accrued Expenses
0.22 0.26 0.28 0.67 0.20 0.23 0.47 0.42 0.45 0.43 1.60
Dividends Payable
- - 4.59 3.80 3.94 5.12 7.35 1.57 4.46 3.15 0.66
Total Noncurrent Liabilities
1.93 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Noncurrent Operating Liabilities
1.93 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
12 22 21 21 22 95 20 23 21 18 18
Total Preferred & Common Equity
12 22 21 21 22 95 20 23 21 18 18
Total Common Equity
12 22 21 21 22 95 20 23 21 18 18
Other Equity Adjustments
12 22 21 21 22 95 20 23 21 18 18

Annual Metrics And Ratios for Mesabi Trust

This table displays calculated financial ratios and metrics derived from Mesabi Trust's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/31/2016 1/31/2017 1/31/2018 1/31/2019 1/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025 1/31/2026
DEI Shares Outstanding
13,120,010.00 13,120,010.00 13,120,010.00 13,120,010.00 13,120,010.00 13,120,010.00 - - - - 13,120,010.00
DEI Adjusted Shares Outstanding
13,120,010.00 13,120,010.00 13,120,010.00 13,120,010.00 13,120,010.00 13,120,010.00 - - - - 13,120,010.00
DEI Earnings Per Adjusted Shares Outstanding
0.65 0.74 2.55 3.47 2.29 1.78 - - - - 1.06
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-62.72% 11.99% 216.84% 37.10% -32.36% -18.88% 175.37% -89.17% 195.30% 331.26% -82.23%
EBITDA Growth
-65.44% 14.08% 242.32% 36.31% -34.03% -22.12% 193.77% -92.28% 257.56% 391.35% -85.13%
EBIT Growth
-65.44% 14.08% 242.32% 36.31% -34.03% -22.12% 193.77% -92.28% 257.56% 391.35% -85.13%
NOPAT Growth
-65.44% 14.08% 242.32% 36.31% -34.03% -22.12% 193.77% -92.28% 257.56% 391.35% -85.13%
Net Income Growth
-65.44% 14.08% 242.32% 36.31% -34.03% -22.12% 193.77% -92.28% 257.56% 391.35% -85.13%
EPS Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Growth
-66.13% 53.06% 134.52% 54.17% -23.97% -39.84% 202.02% -77.94% 5.35% 543.14% -84.67%
Free Cash Flow Firm Growth
-65.44% 50.22% 130.39% 55.08% -23.97% -39.84% 202.02% -77.94% 8.61% 522.43% -84.61%
Invested Capital Growth
10.50% -344.86% 193.70% 3.16% -222.41% 104.19% 5,659.93% -141.95% 155.26% -32.25% -59.07%
Revenue Q/Q Growth
0.00% 0.00% -0.77% 6.58% -5.51% 25.10% 11.08% -72.22% 58.08% 0.64% -15.69%
EBITDA Q/Q Growth
0.00% 0.00% -0.92% 5.88% -5.36% 26.54% 12.15% -79.40% 68.33% 1.50% -19.41%
EBIT Q/Q Growth
0.00% 0.00% -0.92% 5.88% -5.36% 26.54% 12.15% -79.40% 68.33% 1.50% -19.41%
NOPAT Q/Q Growth
0.00% 0.00% -0.92% 5.88% -5.36% 26.54% 12.15% -79.40% 68.33% 1.50% -19.41%
Net Income Q/Q Growth
0.00% 0.00% -0.92% 5.88% -5.36% 26.54% 12.15% -79.40% 68.33% 1.50% -19.41%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
-55.53% 142.31% -10.87% 15.59% -8.40% 15.17% 16.22% -60.27% 73.71% 4.16% -25.69%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 18.29% -8.40% 15.17% 16.22% -60.27% 60.02% 4.31% -27.02%
Invested Capital Q/Q Growth
0.00% 0.00% -30.54% -72.50% -277.05% -94.31% -33.64% -4,829.87% -23.06% -75.49% -70.22%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
97.42% 97.69% 99.22% 99.31% 98.96% 98.93% 99.51% 94.90% 98.60% 99.68% 97.04%
EBITDA Margin
88.04% 89.68% 96.89% 96.33% 93.95% 90.20% 96.23% 68.58% 83.03% 94.60% 79.14%
Operating Margin
88.04% 89.68% 96.89% 96.33% 93.95% 90.20% 96.23% 68.58% 83.03% 94.60% 79.14%
EBIT Margin
88.04% 89.68% 96.89% 96.33% 93.95% 90.20% 96.23% 68.58% 83.03% 94.60% 79.14%
Profit (Net Income) Margin
88.04% 89.68% 96.89% 96.33% 93.95% 90.20% 96.23% 68.58% 83.03% 94.60% 79.14%
Tax Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
1,043.32% 0.00% 0.00% 2,269.79% 0.00% 0.00% 2,242.89% 303.47% 0.00% 7,959.21% 2,079.14%
ROIC Less NNEP Spread (ROIC-NNEP)
1,043.32% 0.00% 0.00% 2,269.79% 0.00% 0.00% 2,242.89% 303.47% 0.00% 7,959.21% 2,079.14%
Return on Net Nonoperating Assets (RNNOA)
-881.83% 0.00% 0.00% -1,937.39% 0.00% 0.00% -1,951.95% -278.32% 0.00% -7,538.13% -2,015.71%
Return on Equity (ROE)
161.48% 101.73% 321.19% 332.40% 209.91% 165.38% 290.94% 25.14% 117.13% 421.08% 63.43%
Cash Return on Invested Capital (CROIC)
1,033.34% 0.00% 1,484.74% 2,266.68% 0.00% 19,885.03% 2,049.72% 0.00% 1,077.71% 7,997.66% 2,162.96%
Operating Return on Assets (OROA)
85.96% 81.14% 165.17% 147.74% 101.71% 100.51% 178.98% 15.61% 93.04% 145.27% 22.00%
Return on Assets (ROA)
85.96% 81.14% 165.17% 147.74% 101.71% 100.51% 178.98% 15.61% 93.04% 145.27% 22.00%
Return on Common Equity (ROCE)
161.48% 101.73% 321.19% 332.40% 209.91% 165.38% 290.94% 25.14% 117.13% 421.08% 63.43%
Return on Equity Simple (ROE_SIMPLE)
95.21% 95.67% 315.12% 271.09% 254.04% 142.06% 223.30% 46.42% 90.50% 399.84% 0.00%
Net Operating Profit after Tax (NOPAT)
8.56 9.76 33 46 30 23 69 5.31 19 93 14
NOPAT Margin
88.04% 89.68% 96.89% 96.33% 93.95% 90.20% 96.23% 68.58% 83.03% 94.60% 79.14%
Net Nonoperating Expense Percent (NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - - 399.84% 67.97%
Cost of Revenue to Revenue
2.58% 2.31% 0.78% 0.69% 1.04% 1.07% 0.49% 5.10% 1.40% 0.32% 2.96%
SG&A Expenses to Revenue
0.71% 1.06% 0.15% 0.86% 0.77% 1.32% 0.07% 0.68% 1.44% 0.51% 1.04%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
9.38% 8.01% 2.32% 2.98% 5.01% 8.73% 3.28% 26.32% 15.57% 5.07% 17.90%
Earnings before Interest and Taxes (EBIT)
8.56 9.76 33 46 30 23 69 5.31 19 93 14
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
8.56 9.76 33 46 30 23 69 5.31 19 93 14
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.19 9.30 18.15 14.15 16.59 15.63 10.73 25.50 12.20 13.27 20.97
Price to Tangible Book Value (P/TBV)
3.19 9.30 18.15 14.15 16.59 15.63 10.73 25.50 12.20 13.27 20.97
Price to Revenue (P/Rev)
2.95 8.72 5.58 5.03 6.13 9.92 4.62 37.67 11.20 3.14 24.41
Price to Earnings (P/E)
3.35 9.73 5.76 5.22 6.53 11.00 4.81 54.93 13.48 3.32 30.84
Dividend Yield
4.12% 8.84% 17.24% 16.55% 17.85% 7.29% 16.48% 22.72% 3.69% 29.36% 3.93%
Earnings Yield
29.87% 10.28% 17.36% 19.15% 15.32% 9.09% 20.81% 1.82% 7.42% 30.12% 3.24%
Enterprise Value to Invested Capital (EV/IC)
23.07 0.00 85.21 100.49 0.00 2,246.90 46.91 0.00 166.04 221.24 1,044.18
Enterprise Value to Revenue (EV/Rev)
2.04 7.42 4.88 4.33 5.40 9.06 3.96 35.87 10.15 2.12 23.09
Enterprise Value to EBITDA (EV/EBITDA)
2.32 8.28 5.04 4.50 5.75 10.04 4.11 52.30 12.22 2.25 29.17
Enterprise Value to EBIT (EV/EBIT)
2.32 8.28 5.04 4.50 5.75 10.04 4.11 52.30 12.22 2.25 29.17
Enterprise Value to NOPAT (EV/NOPAT)
2.32 8.28 5.04 4.50 5.75 10.04 4.11 52.30 12.22 2.25 29.17
Enterprise Value to Operating Cash Flow (EV/OCF)
2.42 6.42 5.71 4.50 4.99 11.30 4.50 20.03 15.88 2.23 28.09
Enterprise Value to Free Cash Flow (EV/FCFF)
2.34 6.35 5.74 4.50 4.99 11.30 4.50 20.03 15.41 2.23 28.04
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.85 -1.07 -1.01 -0.85 -1.02 -1.08 -0.87 -0.92 -1.03 -0.95 -0.97
Leverage Ratio
1.88 1.25 1.94 2.25 2.06 1.65 1.63 1.61 1.26 2.90 2.88
Compound Leverage Factor
1.88 1.25 1.94 2.25 2.06 1.65 1.63 1.61 1.26 2.90 2.88
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
25.68 18.15 13.40 13.80 16.24 29.31 14.80 68.27 31.02 6.64 68.52
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
11.31 7.33 1.68 1.90 2.54 3.55 2.33 37.06 4.67 1.30 6.16
Quick Ratio
10.06 7.28 1.67 1.90 2.53 3.51 2.26 36.72 4.54 1.29 6.06
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
8.48 13 29 45 35 21 63 14 15 94 14
Operating Cash Flow to CapEx
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.98 0.90 1.70 1.53 1.08 1.11 1.86 0.23 1.12 1.54 0.28
Accounts Receivable Turnover
0.00 0.00 0.00 22.02 26.56 162.67 29.28 3.33 23.05 63.18 18.04
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
3,240,502.67 3,629,064.33 11,498,471.67 15,764,588.33 10,663,624.67 8,650,189.00 23,819,930.00 2,580,658.00 7,620,676.33 32,865,217.00 5,841,260.33
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)
0.00 0.00 0.00 16.57 13.74 2.24 12.47 109.73 15.84 5.78 20.24
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
0.00 0.00 0.00 16.57 13.74 2.24 12.47 109.73 15.84 5.78 20.24
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
0.86 -2.11 1.98 2.04 -2.50 0.10 6.03 -2.53 1.40 0.95 0.39
Invested Capital Turnover
11.85 -17.45 -518.91 23.56 -140.09 -21.71 23.31 4.43 -40.43 84.13 26.27
Increase / (Decrease) in Invested Capital
0.08 -2.97 4.08 0.06 -4.53 2.60 5.92 -8.56 3.93 -0.45 -0.56
Enterprise Value (EV)
20 81 168 205 173 235 283 278 232 209 405
Market Capitalization
29 95 192 238 196 258 330 292 256 310 428
Book Value per Share
$0.69 $0.78 $0.81 $1.28 $0.90 $1.26 $2.35 $0.87 $1.60 $1.78 $1.56
Tangible Book Value per Share
$0.69 $0.78 $0.81 $1.28 $0.90 $1.26 $2.35 $0.87 $1.60 $1.78 $1.56
Total Capital
8.99 10 11 17 12 16 31 11 21 23 20
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-8.78 -14 -24 -33 -24 -22 -48 -14 -24 -100 -23
Capital Expenditures (CapEx)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.21 -1.85 -14 -16 -9.17 -5.93 -17 -0.23 -3.01 -77 -2.76
Debt-free Net Working Capital (DFNWC)
8.53 12 11 17 14 16 31 14 21 23 20
Net Working Capital (NWC)
8.53 12 11 17 14 16 31 14 21 23 20
Net Nonoperating Expense (NNE)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Obligations (NNO)
-8.13 -12 -8.63 -15 -14 -16 -25 -14 -20 -22 -20
Total Depreciation and Amortization (D&A)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital to Revenue
2.11% -16.96% -39.15% -34.25% -28.66% -22.85% -23.70% -2.97% -13.15% -77.97% -15.75%
Debt-free Net Working Capital to Revenue
87.78% 113.02% 30.75% 35.53% 44.83% 63.49% 43.09% 177.43% 91.75% 23.66% 116.43%
Net Working Capital to Revenue
87.78% 113.02% 30.75% 35.53% 44.83% 63.49% 43.09% 177.43% 91.75% 23.66% 116.43%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.65 $0.73 $2.55 $3.47 $2.29 $1.78 $5.24 $0.41 $1.45 $7.11 $1.06
Adjusted Weighted Average Basic Shares Outstanding
13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding
13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M
Normalized Net Operating Profit after Tax (NOPAT)
6.34 7.11 24 32 22 17 49 4.68 15 68 11
Normalized NOPAT Margin
65.19% 65.35% 68.57% 68.37% 67.80% 67.07% 69.05% 60.41% 66.00% 68.96% 64.56%
Pre Tax Income Margin
88.04% 89.68% 96.89% 96.33% 93.95% 90.20% 96.23% 68.58% 83.03% 94.60% 79.14%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
104.24% 73.91% 58.49% 80.35% 146.67% 93.60% 54.57% 897.06% 24.19% 18.99% 659.37%
Augmented Payout Ratio
104.24% 73.91% 58.49% 80.35% 146.67% 93.60% 54.57% 897.06% 24.19% 18.99% 659.37%

Quarterly Metrics And Ratios for Mesabi Trust

This table displays calculated financial ratios and metrics derived from Mesabi Trust's official financial filings.

Metric Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027 Q2 2027
Period end date 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 10/31/2025 1/31/2026 4/30/2026 7/31/2026
DEI Shares Outstanding
- - - - - 13,120,010.00 13,120,010.00 13,120,010.00 13,120,010.00 13,120,010.00 13,120,010.00
DEI Adjusted Shares Outstanding
- - - - - 13,120,010.00 13,120,010.00 13,120,010.00 13,120,010.00 13,120,010.00 13,120,010.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - 0.28 0.36 0.21 0.21 0.08 -0.01
Growth Metrics
- - - - - - - - - - -
Revenue Growth
386.72% 238.08% -34.37% 1,513.58% 10.04% -24.25% -13.61% -95.46% -47.59% -52.56% -55.76%
EBITDA Growth
255.58% 240.50% -41.22% 1,816.89% 29.34% 4.23% -12.12% -96.47% -55.07% -70.05% -102.00%
EBIT Growth
255.58% 240.50% -41.22% 1,816.89% 29.34% 4.23% -12.12% -96.47% -55.07% -70.05% -102.00%
NOPAT Growth
322.26% 240.50% -41.22% 1,816.89% 29.34% 4.23% -12.12% -96.47% -55.07% -70.05% -101.40%
Net Income Growth
255.58% 240.50% -41.22% 1,816.89% 29.34% 4.23% -12.12% -96.47% -55.07% -70.05% -102.00%
EPS Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Growth
1,151.92% 389.93% -18.12% 1,415.26% 66.28% -16.90% 14.96% -95.50% -52.91% -74.35% -94.31%
Free Cash Flow Firm Growth
-88.13% -80.79% -38.32% 3,337.82% 751.64% 112.40% 32.90% -93.01% -49.59% -30.93% -75.94%
Invested Capital Growth
155.26% 297.81% 44.11% 112.68% -32.25% 22.82% -49.97% -66.31% -59.07% -78.32% -114.10%
Revenue Q/Q Growth
27.20% 0.36% 3.83% 1,117.30% -91.33% -30.92% 18.42% -35.96% 0.04% -37.48% 10.44%
EBITDA Q/Q Growth
14.80% -25.73% 54.94% 1,351.04% -92.25% -40.15% 30.64% -41.66% -1.49% -60.11% -108.74%
EBIT Q/Q Growth
14.80% -25.73% 54.94% 1,351.04% -92.25% -40.15% 30.64% -41.66% -1.49% -60.11% -108.74%
NOPAT Q/Q Growth
14.80% -25.73% 54.94% 1,351.04% -92.25% -40.15% 30.64% -41.66% -1.49% -60.11% -106.12%
Net Income Q/Q Growth
14.80% -25.73% 54.94% 1,351.04% -92.25% -40.15% 30.64% -41.66% -1.49% -60.11% -108.74%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
9.65% -55.76% 52.00% 1,955.07% -87.97% -77.89% 110.28% -19.61% 26.00% -87.96% -53.32%
Free Cash Flow Firm Q/Q Growth
-65.51% 105.58% 190.94% 1,566.45% -91.46% -48.73% 82.05% -12.41% -38.34% -29.74% -36.59%
Invested Capital Q/Q Growth
-23.06% -9.18% 111.24% 44.07% -75.49% 64.65% -13.96% -2.97% -70.22% -12.80% -155.95%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
132.47% 55.74% 83.17% 99.14% 161.52% 76.70% 84.61% 77.08% 163.20% 48.42% -3.83%
EBITDA Margin
75.32% 55.74% 83.17% 99.14% 88.53% 76.70% 84.61% 77.08% 75.90% 48.42% -3.83%
Operating Margin
75.32% 55.74% 83.17% 99.14% 88.53% 76.70% 84.61% 77.08% 75.90% 48.42% -3.83%
EBIT Margin
75.32% 55.74% 83.17% 99.14% 88.53% 76.70% 84.61% 77.08% 75.90% 48.42% -3.83%
Profit (Net Income) Margin
75.32% 55.74% 83.17% 99.14% 88.53% 76.70% 84.61% 77.08% 75.90% 48.42% -3.83%
Tax Burden Percent
100.00% 100.00% 100.00% 99.41% 108.37% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent
100.00% 100.00% 100.00% 100.60% 92.28% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 4,843.35% 874.25% 3,421.29% 7,448.02% 5,266.44% 4,047.66% 620.57% 1,993.85% 767.74% -55.44%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 4,843.35% 874.25% 3,421.29% 7,448.02% 5,266.44% 4,047.66% 620.57% 1,993.85% 767.74% -55.29%
Return on Net Nonoperating Assets (RNNOA)
0.00% -4,751.58% -783.54% -3,254.49% -7,053.99% -4,896.62% -3,685.09% -593.05% -1,933.03% -729.38% 53.72%
Return on Equity (ROE)
117.13% 91.77% 90.72% 166.80% 394.03% 369.82% 362.57% 27.52% 60.83% 38.36% -1.72%
Cash Return on Invested Capital (CROIC)
1,077.71% 1,539.30% 741.64% 3,164.88% 7,997.66% 6,587.42% 4,680.00% 765.82% 2,162.96% 1,323.05% 0.00%
Operating Return on Assets (OROA)
84.39% 76.49% 82.45% 153.35% 135.94% 283.32% 319.03% 25.30% 21.10% 29.50% -2.04%
Return on Assets (ROA)
84.39% 76.49% 82.45% 153.35% 135.94% 283.32% 319.03% 25.30% 21.10% 29.50% -2.04%
Return on Common Equity (ROCE)
117.13% 91.77% 90.72% 166.80% 394.03% 369.82% 362.57% 27.52% 60.83% 38.36% -1.72%
Return on Equity Simple (ROE_SIMPLE)
0.00% 103.82% 79.85% 96.41% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
4.69 3.48 5.40 78 6.07 3.63 4.74 2.77 2.73 1.09 -0.07
NOPAT Margin
75.32% 55.74% 83.17% 99.14% 88.53% 76.70% 84.61% 77.08% 75.90% 48.42% -2.68%
Net Nonoperating Expense Percent (NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -0.15%
Return On Investment Capital (ROIC_SIMPLE)
- - - 82.17% 26.01% 18.52% 20.82% 13.12% 13.36% 5.93% -0.38%
Cost of Revenue to Revenue
-32.47% 44.26% 16.83% 0.86% -61.52% 23.30% 15.39% 22.92% -63.20% 51.58% 103.83%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
57.15% 0.00% 0.00% 0.00% 72.99% 0.00% 0.00% 0.00% 87.31% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)
4.69 3.48 5.40 78 6.07 3.63 4.74 2.77 2.73 1.09 -0.10
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
4.69 3.48 5.40 78 6.07 3.63 4.74 2.77 2.73 1.09 -0.10
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
12.20 10.21 10.43 3.32 13.27 18.13 16.85 21.24 20.97 19.88 16.40
Price to Tangible Book Value (P/TBV)
12.20 10.21 10.43 3.32 13.27 18.13 16.85 21.24 20.97 19.88 16.40
Price to Revenue (P/Rev)
11.20 7.74 9.67 3.23 3.14 3.66 3.99 21.55 24.41 24.25 24.23
Price to Earnings (P/E)
13.48 9.84 13.06 3.44 3.32 3.81 4.14 26.03 30.84 32.19 44.48
Dividend Yield
3.69% 6.28% 7.45% 5.60% 29.36% 26.57% 23.99% 20.42% 3.93% 3.45% 4.05%
Earnings Yield
7.42% 10.16% 7.66% 29.04% 30.12% 26.27% 24.17% 3.84% 3.24% 3.11% 2.25%
Enterprise Value to Invested Capital (EV/IC)
166.04 149.21 77.97 57.10 221.24 212.61 270.42 326.43 1,044.18 1,019.00 0.00
Enterprise Value to Revenue (EV/Rev)
10.15 6.94 8.76 2.25 2.12 3.41 3.77 20.43 23.09 22.90 22.77
Enterprise Value to EBITDA (EV/EBITDA)
12.22 8.83 11.84 2.40 2.25 3.55 3.91 24.68 29.17 30.40 41.80
Enterprise Value to EBIT (EV/EBIT)
12.22 8.83 11.84 2.40 2.25 3.55 3.91 24.68 29.17 30.40 41.80
Enterprise Value to NOPAT (EV/NOPAT)
12.22 8.83 11.84 2.40 2.25 3.55 3.91 24.68 29.17 30.40 41.80
Enterprise Value to Operating Cash Flow (EV/OCF)
15.88 10.53 12.20 2.45 2.23 3.54 3.85 21.91 28.09 26.78 31.05
Enterprise Value to Free Cash Flow (EV/FCFF)
15.41 9.69 12.41 2.45 2.23 3.56 3.85 21.48 28.04 27.45 33.82
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-1.03 -0.98 -0.90 -0.95 -0.95 -0.93 -0.91 -0.96 -0.97 -0.95 -0.97
Leverage Ratio
1.26 1.20 1.10 1.09 2.90 1.31 1.14 1.09 2.88 1.30 1.11
Compound Leverage Factor
1.26 1.20 1.10 1.09 2.67 1.31 1.14 1.09 2.88 1.30 1.11
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
29.25 30.80 36.09 40.22 3.81 32.13 121.05 56.84 67.01 62.96 78.49
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
4.67 5.61 6.35 18.84 1.30 3.51 12.42 5.29 6.16 6.12 8.81
Quick Ratio
4.54 5.24 5.86 18.68 1.29 3.34 11.37 5.03 6.06 5.84 8.15
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.77 1.57 4.58 76 6.52 3.34 6.08 5.33 3.29 2.31 1.46
Operating Cash Flow to CapEx
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.12 1.37 0.99 1.55 1.54 3.69 3.77 0.33 0.28 0.61 0.53
Accounts Receivable Turnover
23.05 16.95 10.85 33.97 63.18 51.84 47.76 7.69 18.04 11.80 9.88
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
7,620,676.33 9,087,917.33 7,954,806.67 32,656,731.33 32,865,217.00 32,359,873.67 32,065,489.00 6,928,359.00 5,841,260.33 5,011,709.00 3,969,576.00
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)
15.84 21.53 33.63 10.75 5.78 7.04 7.64 47.46 20.24 30.93 36.96
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
15.84 21.53 33.63 10.75 5.78 7.04 7.64 47.46 20.24 30.93 36.96
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1.40 1.27 2.68 3.86 0.95 1.56 1.34 1.30 0.39 0.34 -0.19
Invested Capital Turnover
-40.43 86.90 10.51 34.51 84.13 68.67 47.84 8.05 26.27 15.86 20.68
Increase / (Decrease) in Invested Capital
3.93 1.91 0.82 2.05 -0.45 0.29 -1.34 -2.56 -0.56 -1.22 -1.53
Enterprise Value (EV)
232 189 209 221 209 331 363 425 405 344 271
Market Capitalization
256 211 231 316 310 356 384 448 428 365 289
Book Value per Share
$1.60 $1.57 $1.69 $7.27 $1.78 $1.49 $1.74 $1.61 $1.56 $1.40 $1.34
Tangible Book Value per Share
$1.60 $1.57 $1.69 $7.27 $1.78 $1.49 $1.74 $1.61 $1.56 $1.40 $1.34
Total Capital
21 21 22 95 23 20 23 21 20 18 18
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-24 -22 -22 -96 -100 -24 -21 -23 -23 -20 -17
Capital Expenditures (CapEx)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-3.01 -0.98 0.48 -0.59 -77 -4.61 1.53 -2.10 -2.76 -1.94 0.21
Debt-free Net Working Capital (DFNWC)
21 21 22 95 23 20 23 21 20 18 18
Net Working Capital (NWC)
21 21 22 95 23 20 23 21 20 18 18
Net Nonoperating Expense (NNE)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.03
Net Nonoperating Obligations (NNO)
-20 -19 -19 -91 -22 -18 -21 -20 -20 -18 -18
Total Depreciation and Amortization (D&A)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital to Revenue
-13.15% -3.58% 2.03% -0.60% -77.97% -4.75% 1.59% -10.12% -15.75% -12.93% 1.72%
Debt-free Net Working Capital to Revenue
91.75% 75.76% 92.67% 97.30% 23.66% 20.20% 23.68% 101.46% 116.43% 121.99% 147.71%
Net Working Capital to Revenue
91.75% 75.76% 92.67% 97.30% 23.66% 20.20% 23.68% 101.46% 116.43% 121.99% 147.71%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.36 $0.27 $0.41 $5.97 $0.46 $0.28 $0.36 $0.21 $0.21 $0.08 ($0.01)
Adjusted Weighted Average Basic Shares Outstanding
13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding
13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M 13.12M
Normalized Net Operating Profit after Tax (NOPAT)
3.28 2.44 3.78 55 4.25 2.54 3.32 1.94 1.91 0.76 -0.07
Normalized NOPAT Margin
52.72% 39.01% 58.22% 69.40% 61.97% 53.69% 59.23% 53.95% 53.13% 33.89% -2.68%
Pre Tax Income Margin
75.32% 55.74% 83.17% 99.74% 81.69% 76.70% 84.61% 77.08% 75.90% 48.42% -3.83%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
24.19% 44.05% 75.04% 18.70% 18.99% 97.32% 101.83% 535.18% 659.37% 148.29% 194.19%
Augmented Payout Ratio
24.19% 44.05% 75.04% 18.70% 18.99% 97.32% 101.83% 535.18% 659.37% 148.29% 194.19%

Financials Breakdown Chart

Key Financial Trends

Mesabi Trust’s financial profile has weakened materially from the unusually strong results reported in 2022. Revenue and earnings have generally declined over the subsequent periods, while the trust has continued distributing substantial cash dividends. The latest quarter shows the clearest deterioration: Q2 2027 revenue was $2.5 million, down from $5.6 million in Q2 2026 and $9.9 million in Q2 2024.

Recent profitability has become volatile. Mesabi Trust earned $1.1 million in Q1 2027, but reported a $95,000 net loss in Q2 2027. Q2 revenue increased approximately 10% sequentially, but operating costs more than doubled to $2.6 million, exceeding revenue and producing a negative gross profit. Earnings per share declined from $0.36 in Q2 2024 and $0.41 in Q2 2025 to a loss of $0.0072 in the latest quarter.

Cash generation remains positive from operations, but it is no longer sufficient to cover the trust’s dividend payments. Operating cash flow fell from $4.4 million in Q4 2026 to $534,000 in Q1 2027 and $249,000 in Q2 2027. At the same time, dividend payments totaled $3.4 million in Q1 and $3.1 million in Q2.

  • Strong liquidity remains: Mesabi Trust held $17.4 million in cash at July 31, 2026, compared with $2.3 million of current liabilities excluding the small amount of noncurrent liabilities. The reported current ratio was approximately 8.8.
  • Minimal traditional debt: The balance sheet contains virtually no long-term debt, limiting interest expense and reducing financial leverage risk.
  • Operating cash flow is still positive: The trust generated $249,000 of operating cash flow in Q2 2027 despite its net loss, helped by a $527,000 favorable change in operating assets and liabilities.
  • Share dilution has not been an issue: Basic and diluted weighted-average shares have remained near 13.1 million across the reported periods.
  • The balance sheet is primarily cash-based: Property, plant and equipment is reported at essentially zero, meaning the trust’s financial strength depends mainly on cash, receivables and royalty-related distributions rather than an expanding operating asset base.
  • Dividend timing creates working-capital swings: Dividends payable rose to $3.1 million at July 31, 2026, after being $3.1 million at April 30, 2026, while prior periods showed substantially larger payable balances. This can make quarterly cash movements appear unusually volatile.
  • Revenue has trended sharply lower: Quarterly revenue fell from $14.2 million in Q1 2023 and $9.9 million in Q2 2024 to $2.2 million in Q1 2027 and $2.5 million in Q2 2027.
  • Profitability has deteriorated: Net income declined from $9.2 million in Q2 2024 to $4.7 million in Q2 2026, $1.1 million in Q1 2027 and a $95,000 loss in Q2 2027.
  • Dividend coverage is weak: Q2 2027 operating cash flow covered only about 8% of the $3.1 million dividend payment. The trust therefore relied on its cash balance to fund the distribution.
  • Cash reserves have fallen substantially: Cash declined from $95.9 million in October 2024 to $17.4 million by July 2026, largely reflecting sizable dividend distributions and the weaker earnings environment.

Overall, Mesabi Trust retains a strong near-term liquidity cushion and little debt, but the trend in the operating business is unfavorable. Investors should focus on whether royalty revenue and operating cash flow stabilize, and whether future dividends are supported by recurring cash generation rather than by drawing down accumulated cash.

10/14/26 07:04 AM ETAI Generated. May Contain Errors.

Mesabi Trust Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Mesabi Trust's financial year ends in January. Their financial year 2026 ended on January 31, 2026.

Mesabi Trust's net income appears to be on an upward trend, with a most recent value of $13.87 million in 2026, rising from $8.56 million in 2016. The previous period was $93.27 million in 2025. View Mesabi Trust's forecast to see where analysts expect Mesabi Trust to go next.

Mesabi Trust's total operating income in 2026 was $13.87 million, based on the following breakdown:
  • Total Gross Profit: $17.00 million
  • Total Operating Expenses: $3.14 million

Over the last 10 years, Mesabi Trust's total revenue changed from $9.72 million in 2016 to $17.52 million in 2026, a change of 80.3%.

In the past 13 quarters, Mesabi Trust's cash and equivalents has ranged from $13.10 million in Q1 2024 to $95.91 million in Q3 2025, and is currently $17.39 million as of their latest financial filing in Q2 2027.

Mesabi Trust had total debt of $0.00 at the end of 2026, compared with none in 2025, and none in 2016.

Over the last 10 years, Mesabi Trust's book value per share changed from 0.69 in 2016 to 1.56 in 2026, a change of 127.0%.



Financial statements for NYSE:MSB last updated on 9/11/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners